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Ischemic acute kidney injury is characterized by renal vasoconstriction, filtration failure, 
tubular obstruction, tubular backleak and overproduction of  angiotensin II and reactive 
oxygen species. Considering this complexity, the aim of  our study was to investigate 
the effects of  angiotensin II type-1 receptor blocker - Losartan and superoxide anion 
scavenger - Tempol, in a combined treatment on acute kidney injury in postischemic 
hypertensive rats.
The experiment was performed in anesthetized, adult male spontaneously hypertensive 
rats. The right kidney was removed and the left renal artery was occluded for 40 minutes. 
Experimental groups received combined treatment (Losartan + Tempol) or saline in 
the femoral vein 5 minutes before, during and 175 minutes after clamp removal.
Hemodynamics and biochemical parameters were measured and kidney specimens 
were collected 24h after reperfusion. Histological examination was performed by 
optical microscopy. 
Combined treatment improves renal haemodynamics parameters which were exacerbated 
due to acute kidney injury. Acute kidney injury significantly decreased creatinine and 
urea clearance and increased lipid peroxidation in the plasma. Treatment with Losartan 
and Tempol induced a significant increase of  creatinine and urea clearance. Lipid 
peroxidation in the plasma decreased and glutathione peroxidase enzyme activity in the 
erythrocytes increased after Losartan + Tempol treatment. This combined treatment 
reduced cortico-medullary necrosis and tubular dilatation in the kidney.
Our results indicate that synergism of  Losartan and Tempol treatment could have 
beneficial effects on blood pressure and kidney function, during postischemic acute 
kidney injury development in experimental hypertension. 
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IntroductIon 
Ischemia/reperfusion (IR) acute kidney injury (AKI) is a complex phenomenon with 
structural and functional changes in the kidney, which ensue mainly due to increased 
generation of  reactive oxygen species (ROS) during reperfusion [1]. The manifestation 
of  this oxygen radical-mediated injury are exacerbation of  glomerular filtration and 
renal haemodynamic, damage of  kidney tissue due to lack of  antioxidative defence 
and free radical-mediated lipid peroxidation, as well as increased level of  vasoactive 
Angiotensin II. [2-5]
Angiotensin II (AngII), as one of  the main vasoactive signaling molecules, is involved 
in the generation of  ROS. Overproduction of  AngII during ischemic AKI [3] may 
cause an increased expression and activity of  one of  the major ROS generators, 
NADPH oxidase [6]. Also,due to intrarenal vasoconstriction, high level of  AngII has 
harmful effects on morphological changes in the kidney tissue [2,4]. 
Beside IR injury, the pathology of  hypertension is closely related to oxidative 
stress. There are many reports about this relation in humans (humans with essential 
hypertension, preeclampsia during pregnancy) and animal studies (spontaneously 
hypertensive,Dahl saltsensitive, or AngII–infused rat) [7].
This clearly implicates the important role of  oxidants in the pathophysiology of  the 
hypertensive postischemic kidney. This fact directed the focus of  our study towards 
the influence of  these two pathogenetic factors, hypertension and ROS, in the 
development and progression of  AKI.
The protective effect of  supplementation with antioxidant enzymes [1] and blockade 
of  generators of  ROS, such as NADPH oxidase [8], against IR induced oxidative 
stress provide unequivocal evidence that ROS has a great impact on the degree 
of  tissue damage. Our previous studies showed positive effects of  Losartan on 
oxidative stress, as well as on renal function and structure in the postischemic injured 
hypertensive kidney [5]. On the other side, superoxide dismutase mimetic, Tempol, 
also showed some beneficial effects on renal haemodynamic and oxidative status in the 
postischemic hypertensive kidney [9].
The goal of  our study was to examine the effects of  the combination (LT) - 
antihypertensive (Losartan) and antioxidative (Tempol) supplementation on kidney 
function and morfological changes in spontaneously hypertensive rats (SHR), during 
ischemic AKI development.
MaterIal and Methods
In our study we used 24 weeks old male SHR, weighting about 300 g, which were bred 
at the Institute for Medical Research, University of  Belgrade, Serbia, and fed with a 
standard chow for laboratory rats (Veterinarski zavod, Subotica, Serbia).
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Ethics Statement
The experimental protocol was approved by the Ethic Committee of  the Institute for 
Medical Research, University of  Belgrade, Serbia (No. 0148.1/10), according to the 
National Law on Animal Welfare (“Službeni Glasnik” no. 41/09) that is consistent 
with guidelines for animal research and principles of  the European Convention for 
the Protection of  Vertebrate Animals Used for Experimental and Other Purposes 
(Official Daily N. L 358/1-358/6, 18, December 1986) and Directive on the protection 
of  animals used for scientific purposes (Directive 2010/63/EU of  the European 
Parliament and of  the Council, 22.9.2010.).
Experimental protocol
Animals were divided into the following groups: sham-operated rats (SHAM, n=7), 
rats with AKI (AKI, n=7) and animals which received the combination of  AT1R 
antagonist - Losartan (DUP 153, Du Pont, Wilmington, DE, USA) and 4-Hydroxy-2, 
2, 6, 6 tetramethylpiperidine-N-oxyl – Tempol (Sigma Chemical Co. St. Louis, MO, 
USA) after AKI induction (AKI+LT, n=9). 
For surgical procedure, all rats were anaesthetized with 35 mg/kg b.m. sodium 
pentobarbital. AKI was induced by right kidney nephrectomy and atraumatic occlusion 
of  the left renal artery for 40 minutes. SHAM and AKI rats received the vehicle (saline, 
4ml), while AKI+LT group received a combination of  Losartan (10 mg/kg b.m.) and 
Tempol (40mg/kg/h b.m.) dissolved in 4 ml saline, in the femoral vein 5 minutes 
before, during and 175 minutes after clamping. After infusion, abdominal incision was 
closed with several sutures and SHR were placed into metabolic cages for 24h urine 
collection, having free access to water and chow.
Haemodynamic measurements after 24h
Haemodynamic parameters were measured in anaesthetized rats, through a femoral 
artery catheter (PE–50, Clay-Adams Parsippany, NY, USA), connected to a 
physiological data acquisition system (9800TCR Cardiomax III-TCR Thermodilution 
Cardiac Output for mice, rats and large subjects, Columbus Instruments’, Columbus, 
OH, USA). A jugular vein was cannulated with polyethylene tubing PE-50 for the 
injection of  cold saline. The right carotid artery was catheterized with PE-50 tubing 
and attached to a thermo sensor, which was coupled to the Cardiomax III for the 
determination of  cardiac output (CO). The other end of  the thermocouple was placed 
in cold saline. Following 20 min. for stabilization after surgery, cold saline (0.2ml) was 
supplied through the jugular vein and mean arterial pressure (MAP) and CO were 
recorded. Total peripheral vascular resistance (TPVR) was calculated by dividing MAP 
with CO normalized for  body weight and expressed as mmHg x min x kg/ml. 
The prepared  left renal artery was utilized for renal blood flow (RBF) recording, using 
a Transonic T106 Small Animal Flowmeter (Transonic System Inc., Ithaca, NY, USA). 
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Vascular resistance in this vascular bed (RVR) was calculated by dividing MAP with 
RBF, normalized for body weight and expressed as mmHg x min x kg/ml.
Biochemical measurements 24 h after reperfusion
After haemodynamic measurements, blood samples were taken for determination 
of  creatinine (PCr), urea (PU) and phosphates (PPhos) in plasma. Lithium-heparin (Li-
heparin, Sigma, USA) was used as an anticoagulant. 24h urine samples were used 
for the determination of  urine creatinine (UCr) and urea (UU) concentrations. All 
biochemical parameters were measured using an automatic COBAS INTEGRA 
400 plus (Hoffmann-La Roche, Germany) analyzer. Creatinine (CCr) and urea (CU) 
clearances were calculated according to standard formula and normalized to body 
weight. After blood samples collection, animals were sacrificed by pentobarbital 
overdose injection.
Oxidative stress parameters
To determine the degree of  lipid peroxidation, the concentration of  thiobarbituric acid 
reactive substances (TBARS) in the  plasma was measured [10]. Antioxidant enzymes 
activities of  the erythrocytes were measured by spectrophotometry. Catalase (CAT) 
activity was measured by the depletion of  H2O2 [11]. Glutathione reductase (GR) 
activity was measured using the method developed by Glatzle et al.[12] Superoxide 
dismutase (SOD) activity was measured according to McCord and Fridovich, where 
we evaluated a decrease of  cytochrome c reduction [13]. Activity of  glutathione 
peroxidase (GSH-Px) was determined by the method previously described by Paglia 
and Valentine [14].
Morphological and immunohistological examination
For the morphological analysis of  the left kidney, renal tissue was prepared as 
described previously [4], and stained by hematoxilin eosine (H&E) and periodic 
acid-Schiff  (PAS). Intensity and spread of  tubular necrosis, number of  intra-luminal 
cast formations, swelling and vacuolization of  cells, loss of  luminal membrane or 
brush borders, tubular dilatation, interstitial oedema and separation of  cells from the 
tubular basal membrane were semi-quantitatively evaluated as described previously 
[4]. The level of  each manifestation was graded with 1 for low, 2 for moderate, 3 for 
high, and 0 for the lack of  manifestation. The sum of  these changes represented the 
histopathological score.
Statistical analysis
The results are shown as the mean, with the standard error of  the mean. We used the 
single-sided Student’s t-test for two-samples of  equal variance, and value p<0.05 was 
considered notable (Microsoft Excel 2010).




Haemodynamics parametrs, 24 h after reperfusion, are shown in Table 1. The MAP 
was significantly decreased in AKI group, in comparison to SHAM. Furthermore, 
in the AKI+LT group, MAP was significantly decreased in comparison to AKI. 
There were no differences in CO and TPVR between experimental groups. The 
significant decline of  RBF in AKI group (p<0,01) and concomitant increase of  RVR 
(p<0,01;compared to SHAM), were completely abolished with LT infusion. Namely, 
LT treatment markedly increased RBF (AKI+LT vs. AKI;  p<0,05) and decreased 
RVR in hypertensive rats with AKI (AKI+LT vs. AKI;  p<0,01)  (Fig. 1). 








mmHg 147.1±5.6 119.2±3.5*** 60.3±7.4
###
CO
ml/min/kg 281.7±45.8 289.8±45.2 231.3±32.7
TPVR
mHg x min x kg/ml 0.74±0.1 0.51±0.11 0.34±0.05
MAP-mean arterial pressure; CO- cardiac output; TPVR- total peripheral vascular resistance. 
n-number of  animals. *** p < 0.001 compared to SHAM; ### p < 0.001 compared to AKI.
Figure 1. Renal haemodynamic parameters of  SHR. RBF- renal blood flow, RVR – renal 
vascular resistance, SHAM - sham operated SHR (n=7), AKI - SHR with acute renal failure 
(n=7), AKI+LT - SHR received Losartan and Tempol after AKI (n=9). *p < 0.05, **p < 0.01 
vs. SHAM; #p < 0.05, ##p < 0.01 vs. AKI; n-number of  animals.
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Biochemical parameters
Significantly higher levels of  PCr, PU and PPhos were found in AKI group in comparison 
to SHAM (AKI vs. SHAM; p<0,001). LT treatment markedly decreased PCr (AKI+LT 
vs. AKI;  p<0,01) , as well as PU and PPhos (AKI+LT vs. AKI;  p<0,05)  concentrations 
in comparison to AKI (Fig. 2). 
In the urine samples, due to AKI induction, both creatinine and urea levels were 
significantly decreased compared to SHAM. The treatment with LT improved urea 
concentration in urine, but did not effect creatinine concentration (Table 2). CCr and 
CU were markedly lower due to the induction of  AKI. However, CCr and CU were 
significantly improved after LT treatment, compared to AKI group. (Table 2).







UCr  mmol/l 6.31±1.05 2.39±0.45** 3.00±0.35
UU mmol/l 908±173 227±43** 333±40
##
CCr ml/min/kg 6.50 ± 0.99 0.29 ± 0.13*** 0.76±0.12
##
CU ml/min/kg 2.38 ± 0.28 0.10 ± 0.05*** 0.27±0.04
#
UCr- urine creatinine; UU-urine urea; CCr-creatinine clearance; CU-urea clearance. n-number of  animals.  
** p < 0.01, *** p < 0.001 compared to SHAM; # p < 0.05, ## p < 0.01 compared to AKI.
Figure 2. Plasma creatinine (Pcr), urea (Pu), and phosphates (Pphos) concentrations of  SHR. 
SHAM - sham operated SHR (n=7), AKI - SHR with acute renal failure (n=7), AKI+LT - SHR 
received Losartan and Tempol after AKI (n=9). ***p < 0.001 vs. SHAM; #p < 0.05, ##p < 
0.01 vs. AKI; n-number of  animals.
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Oxidative stress parameters
AKI injured rats showed a significant increase in lipid peroxidation compared to 
SHAM operated animals. LT treatment significantly decreased plasma TBARS 
compared to the rats with induced AKI. The levels of  antioxidative enzyme activity 
in erythrocytes: catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase 
(GSH-Px) and glutathione reductase (GR) were shown in Table 3. GSH-Px activity 
shows moderate, but not significant decrease in AKI vs. SHAM operated group. LT 
significantly increased activity of  GSH-Px in comparison to AKI group. SOD, CAT 
and GR activity, were not different between groups.












22.15 ± 6.05 14.32 ± 2.91 14.3 ± 4.71
eGR
(µmol NADPH/min/g Hb) *103 5.6 ± 1.8 4.9 ± 1.2 12.1 ± 3.9
eGSH-Px
(µmol NADPH/min/g Hb) 185.1 ± 59.4 152.44 ± 27.1 270.6 ± 40.1
#
eSOD
(U/g Hb)*103 1.6 ± 0.4 1.5 ± 0.5 1.7 ± 0.4
TBARS - thiobarbituric acid reactive substances; CAT - catalase activity; GR -glutathione reductase 
activity; GSH-Px - glutathione peroxidase activity; SOD - superoxide dismutase activity. Data are 
presented as mean ± SEM; n-number of  animals; p-plasma; e- erythrocyte; **p<0.01 compared with 
SHAM; #p<0.05 compared with AKI.
Histological studies
There were significant differences in pathomorphological parameters between 
experimental groups. Fig. 3a shows the normal appearance of  glomeruli, interstitium, 
tubules and blood vessels in SHAM operated animals. Only in a few kidney specimens 
we observed smaller number of  PAS positive casts in the lumen of  the tubules. The 
kidneys of  animals with AKI showed dilatation of  certain segments of  the proximal 
and distal tubules, with or without loss of  brush-border. The most notable changes 
were present in the cortico-medullary zone, where the broad areas of  tubular necrosis 
and a large number of  PAS positive casts in the collecting ducts were observed. The 
intensity of  interstitial edema in this group varies from sample to sample (Fig. 3b). 
In LT treated animals, less damages were noticed in comparison to renal tissue of  
AKI animals. Tubular dilatations were  smaller, and tubular necrosis in the cortico-
medullary zone, was reduced. Interstitial edema is rarely observed. In addition, the 
number of  tubular casts in the renal medulla is lower, compared to AKI animals (Fig. 
3c). The histopathological score (Fig. 3d) shows the sum of  these changes (AKI vs. 
SHAM,  p<0,001; AKI+LT vs. AKI,  p<0,01).
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dIscussIon
In the presented study we investigated the effects of  concomitant AT1R blockade and 
O2
- scavenging in hypertensive rats with ischemic AKI. The significance of  their roles 
is evaluated on the basis of   biochemical and histological  parameters, as well as the 
activities of  antioxidative enzymes and lipid peroxidation as a parameters of  oxidative 
stress.
After AKI induction, we noticed mild MAP reduction, similar to the results of  
Bowmer at al. [15] performed in the model of  glycerol induced AKI. These authors 
considered high uremia (plasma urea was significantly elevated in the AKI group in 
our study as well) and its influence on the autonomic nervous system (diminished α1 
adrenoreceptors sensitivity) as a cause of  MAP reduction after AKI. Dobrian et al [7] 
Figure 3A. Normal appearance of  glomeruli, interstitium, tubules and blood vessels in SHAM 
operated animals. Very rare PAS positive casts in the lumen of  the tubules
Figure 3B. Massive cortico-medullary tubular necrosis. Intensive interstitial edema. Numerous 
PAS positive casts in the collecting ducts and dilatation of  certain segments of  the proximal 
and distal tubules, (with or without loss of  brush-border) in the AKI control group.
Figure 3C. Moderately intensive tubular necrosis in LT treated rats, reduced tubular dilatation 
and less number of  PAS-positive casts.
Figure 3D. Histopathological score in experimental groups 24h after reperfusion. SHAM, 
n=7; AKI, n=7; AKI+LT, n=9 (n-number of  animals). Data are presented as mean ± SEM 
(***p<0.001 compared with SHAM; ##p<0.01 compared with AKI)
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showed that only the combined treatment with LT (and not a single treatment with 
Losartan or Tempol) decreases MAP to control values in the model of  1K1C induced 
hypertension. These results are similar to ours where combined treatment with LT 
decreases MAP to the physiological level in the group of  SHR with IR induced AKI.
Renal dysfunction in this model was characterized by the rapid fall in renal blood 
flow and increase of  renal vascular resistance, accompanied with the decrease of  both 
urea and creatinine clearances. In our study, RBF was significantly reduced, followed 
by enhanced RVR in postishaemic SHR twenty-four hours after AKI induction. 
Intrarenal vasoconstriction is one of  the main factors involved in the initiation and 
maintenance of  AKI [16]. It is well known that Losartan and Tempol could have 
beneficial effects on renal haemodynamics [4,9,17,18]. Miloradović et al. showed that 
Losartan (10 mg/kg b.w.) strongly increases RBF after moderate NO deficiency in the 
kidney of  postischemic Wistar rats [4]. On the other side, Schnackenberg et al. pointed 
that Tempol (12.4 mg/kg t.m.) significantly reduces RVR, without influencing RBF 
in SHR [17]. Considering that IR injury is a well known generator of  ROS, Tempol 
treatment can be useful for the regulation of  renal haemodynamic in increased 
oxidative stress [18]. In our model of  ischemic AKI induced in SHR, treatment with 
Tempol in combination with Losartan, beside auspicious effects on RVR [17], had 
beneficial effects on RBF, too. That implies significant roles of  Ang II and superoxide 
radicals on renal haemodynamic in the present model of  ischemia-reperfusion.
Our study shows that postischemic kidney damage decreases creatinine clearance 
twenty time fold, indicating adjunctive reduction of  glomerular filtration rate (GFR) 
in postischemic hypertensive kidney. GFR (expressed by clearence creatinine) is one 
of  the most important markers of  AKI. It is well known that Losartan has beneficial 
effects on renal function. Kontogiannis and Burns showed that blockade of  AT1 
receptors with Losartan accelerates the recovery of  renal function, leading to a 
significant decrease in serum creatinine, after 60 minutes bilateral occlusion of  the 
male Sprague-Dawley rats renal hilum [3]. In another study, Miloradović et al. showed 
that Losartan led to a slight GFR improvement in postischemic kidney of  Wistar 
rats, after moderate blockade of  NO synthase [4]. On the other side, our previous 
results showed that Tempol did not improve GFR in SHR with ischemic AKI [9]. 
Oposite to our results, Chatterjee at al. showed that Tempol treatment improves GFR 
in normotensive surroundings [19]. Our results correlate with these findings because 
combined treatment with anti-hypertensive Losartan, and SOD mimetic Tempol, 
doubled creatinine clearance in SHR with AKI. 
Hyperphosphatemia is an important marker of  tubular damage in AKI. Rubinger at 
al., showed that hyperphosphataemia is a result of  reduced expression of  sodium-
dependent phosphate cotransporter in tubules, which is induced by ischemic damage 
of  kidney tissue [20]. In our previos studies, Losartan produced a significant decrease 
in plasma phosphate [21], due to a better preservation of  tubular structures after 
RAS blockade [5] in hypertensive rats with induced AKI, and thus better excretion of  
phosphate was observed. On the other hand, treatment with SOD mimetic, Tempol, 
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did not result in a significant decrease in plasma phosphate in such conditions [9]. 
Yamada at al. showed beneficial effects of  Tempol during renal failure in high uremic 
rats, despite the fact that Tempol did not improve hyperphosphatemia [22]. We showed 
that beside the improvement in haemodynamics and GFR,  the hyperphosphatemia is 
markedly lower in LT treatment SHR with postischemic kidney injury, as well.
In our model there are two important facts considering ROS generation. It is well 
known that, during ischemic AKI, AngII concentration goes up [3], and Ang II activates 
NADPH oxidase (via AT1 receptors) which can in return generate superoxide anion 
[6]. The second fact is the nature of  I/R injury. I/R injury in moment of  reperfusion 
generates high concentrations of  ROS [23].
Dobrian et al indicated that treatment with Losartan or Tempol alone did not effect 
O2
- generation in a rat model of  renal hypertension (1K1C), but on the other side 
combined treatment with Losartan and Tempol decreases oxidative stress in Sprague-
Dawley rats [7]. Our results are complementary with this study. Blockage of  AT1R 
with Losartan and scavenging O2
- at the same time decrease lipid peroxidation in SHR 
with AKI. This combined treatment increases GSH-Px activity,i.e. the enzyme which 
decomposes a very potent ROS, hydrogen peroxide, down to the water molecule.
Inal at al. showed that renal I/R injury in Sprague-Dawley rats decreases GSH-px 
activity, and treatment with substances which have antioxidant potential could increase 
the activity of  this enzyme [24]. According to these results, a slight reduction in GSH-
Px activity in our study is significantly higher in the LT treated group in SHR with 
AKI. Our previous results suggest that only AT1R blockade could not improve GSH-
Px activity in our experimental model [5]. On the other side, LT treatment, beside 
decreasing lipid peroxidation, increases GSH-Px activity and thus improves antioxidant 
defence.
Histopathological examination is the best way to analyze morphological changes in 
the kidney tissue after AKI development. Broad areas of  necrosis, the most common 
in the cortico-medullary zone, and a large number of  PAS positive casts in the renal 
medulla [25] are the most notable changes in the ischemic kidney that can be seen by 
light microscopy. Morphological changes in the kidneys isolated from our study in 
the control AKI group, entirely correspond to the previous description. Besides the 
mentioned changes, we observed a significant number of  dilated proximal and distal 
tubules.
Numerous studies showed a successful recovery potential of  Losartan and Tempol 
in AKI [4,5,19]. On the other side, our previous study showed that hypertension 
suppressed Tempol recovery capacity [9]. In this study, with a combined treatment 
due to blockage of  AT1 receptor in the early stages of  ischemic AKI in hypertension, 
Tempol could express beneficial effects on renal morphological structure. Beyond 
decreasing MAP to the physiological level, the combined LT treatment also decreased 
the number of  PAS positive casts, and smaller fields of  necrosis were observed, as 
well.
Acta Veterinaria-Beograd 2016, 66 (3), 392-405
402
These histological findings suggest a positive effect of  LT treatment are consistent 
with the improvement of  both systemic and renal artery hemodynamics parameters, 
as well with better biochemical parameters of  kidney function.
conclusIon
This study, for the first time, demonstrated that combined treatment with AT1R 
blocker and O2
- scavenger could have beneficial effects in concomitant model of  
postischemic AKI and hypertension. This study also showed that kidney injuries are 
strongly mediated by Ang II and partly by O2
-. AT1R blockade and O2
- scavenging 
improve glomerular filtration and renal haemodynamic, decrease lipid peroxidation and 
increase antioxidative defense. Furthermore, treatment with LT combination mitigates 
kidney damage in SHR during AKI development, but we did not get expected additive 
protective effects in comparison to our previous study, where animals were treated 
only with Losartan [5]. In comparison to the former results, we conclude that the most 
positive effects in this study are the consequence of  AT1R blockade. These findings 
could be useful in hypertensive patients who develop AKI, but further investigations, 
especially in pre-clinical and clinical studies, are necessary.
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UTICAJ BLOKADE RECEPTORA TIP 1 ZA ANGOTENZIN II 
UDRUŽENE SA UKLANJANJEM SUPEROKSIDNOG ANJONA 
NA POSTISHEMIČNI BUBREG KOD PACOVA SA UROĐENOM 
HIPERTENZIJOM
IVANOV Milan, MIHAILOVIĆ-STANOJEVIĆ Nevena, MARKOVIĆ-
LIPKOVSKI Jasmina, JOVOVIĆ Đurđica, KARANOVIĆ Danijela, 
MILORADOVIĆ Zoran, GRUJIĆ-MILANOVIĆ Jelica
Glavne karakteristike ishemične akutne bubrežne slabosti su: renalna vazokonstrikcija, 
pad glomerulske filtracije, tubularna opstrukcija, vraćanje glomerulskog filtrata u in-
tersticijum tubula i prekomerna produkcija angiotenzina II i reaktivnih vrsta kiseonika. 
Uzimajući u obzir kompleksnost ovog poremećaja, cilj ove studije je bio da istraži 
efekte kombinovanog tretmana blokatora angiotenzin II receptora tip 1 – Losartana 
i  sakupljača superoksidnog anjona – Tempola u modelu ishemične bubrežne slabosti 
kod hipertenzivnih pacova.  
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Eksperiment je urađen na odraslim anesteziranim mužjacima hipertenzivnih pa-
cova. Desni bubreg je uklonjen, dok je na levoj renalnoj arteriji urađena okluzija u 
trajanju od 40 minuta. Eksperimentalne grupe su primile kombinovani tretman 
(Losartan+Tempol) ili fiziološki rastvor u femoralnu venu, 5 minuta pre i 175 minuta 
nakon uklanjanja kleme sa renalne arterije. Hemodinamski i biohemijski parametri su 
izmereni, a uzorci bubrega uzimani su 24 časa nakon reperfuzije. Histološka ispitivanja 
su rađena pomoću svetlosnog mikroskopa.
Kombinovani tretman poboljšava renalnu hemodinamiku, poremećenu usled ishemične 
akutne bubrežne slabosti. U ovom modelu bubrežne slabosti dolazi do pada klirensa 
kreatinina i uree, i povećanja lipidne peroksidacije u plazmi.Tretman Losartanom i 
Tempolom dovodi do značajnog povećanja klirensa kreatinina i uree. Lipidna peroksi-
dacija je smanjena, a aktivnost glutation peroksidaze u eritrocitima je povećana nakon 
kombinovanog tretmana sa Losartanom i Tempolom. Takođe, ovakav kombinovan 
tretman smanjuje kortiko-medularnu nekrozu i tubularnu dilataciju u bubregu.
Naši rezultati ukazuju na to da sinergizam Losartana i Tempola može imati povol-
jan efekat na krvni pritisak i bubrežnu funkciju tokom razvoja postishemične akutne 
bubrežne slabosti u eksperimentalnoj hipertenziji.
